Champlain Investment Partners, LLC Penumbra Inc Transaction History
Champlain Investment Partners, LLC
- $12.7 Billion
- Q3 2025
A detailed history of Champlain Investment Partners, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 717,900 shares of PEN stock, worth $200 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
717,900
Previous 743,710
3.47%
Holding current value
$200 Million
Previous $191 Million
4.72%
% of portfolio
1.44%
Previous 1.41%
Shares
33 transactions
Others Institutions Holding PEN
# of Institutions
472Shares Held
30.6MCall Options Held
309KPut Options Held
95.9K-
Black Rock Inc. New York, NY4.26MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.79MShares$500 Million0.05% of portfolio
-
State Street Corp Boston, MA1.16MShares$324 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il971KShares$270 Million0.04% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.6B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...